Download PDF

Other users also viewed these articles

When can it be useful to look for occult HBV in haemodialysis patients? Rosa María Ruiz-Calero Cendrero, Bárbara Cancho Castellano, María Victoria Martín Hidalgo-Barquero, María Cruz Cid Parra, Josefa Galán González, María Antonia Fernández Solís, Olga Sánchez García
10.1016/j.nefroe.2020.03.008
Position on the management of occult infection by hepatitis B virus (OBI) and anti-HBc + in hemodialysis units Guillermina Barril Cuadrado, Ana Avellón Calvo, Elena Jiménez Vibora, Luisa García Buey, Rosa María Ruiz-Calero Cendrero, Antonio Cirugeda García, José Ibeas López, Cristina García Fernandez, Federico García García, Roberto Alcázar Arroyo
10.1016/j.nefroe.2025.501355
Inflammation and hemodialysis adequacy: are C-reactive protein levels influenced by the dose of dialysis? Francisco Valga, Tania Monzón, Nicanor Vega-Diaz, José Carlos Rodriguez-Perez, Sergio Ruiz-Santana
10.1016/j.nefroe.2021.06.005